Scope: The application of dried blood spot (DBS) cards for the study in human blood of dietary polyphenol bioavailability has been poorly studied. Methods and results: An analytical method based on blood sampling with DBS cards combined with LC-MS/MS has been developed and validated. To test the method validation, the phenolic metabolites are determined in human blood and plasma obtained after an acute intake of a red-fleshed apple snack in ten volunteers. Capillary blood by finger prick is compared to venous blood by venipuncture and whole blood is also compared to their corresponding venous plasma samples. Moreover, the venous plasma results using DBS cards are compared to those obtained by microElution solid phase extraction (µSPE). The main phenolic metabolites detected in blood and plasma samples are phloretin glucuronide, dihydroxyphenylpropionic acid sulphate, (methyl) catechol sulphate, catechol glucuronide, and hydroxyphenyl-γ -valerolactone glucuronide. No significant differences are observed between capillary blood, venous blood, and plasma samples using DBS, and neither between plasma samples analyzed by DBS or µSPE. Conclusions: Finger-prick blood sampling based on DBS appears to be a suitable alternative to the classic invasive venipuncture for the determination of circulating phenolic metabolites in nutritional postprandial studies.
Introduction
Over recent years, there has been a large increase in the reporting of the use of dried blood spot (DBS) cards for therapeutic drug monitoring and quantitative biomarker assessment. [1] It has DOI: 10.1002/mnfr.201800623 established itself as an innovative sampling technique where wet blood is spotted onto absorbent paper offering several potential benefits inherent to the technique, namely being less invasive than venous blood sampling, simplified blood sample collection, and convenient sample storage. [2] The small volume of the blood sample and complexity of the matrix leads to analytical challenges in terms of sensitivity and selectivity that could have hampered the attractiveness of DBS cards. However, these limitations have been overcome by the significant improvement in the sensitivity of current LC-MS/MS instruments. [1] One area that has received less attention in the application of DBS cards as a blood collection technique concerns the evaluation of the pharmacokinetic parameters of food bioactive compounds, such as dietary polyphenols. Red blood cells, particularly erythrocytes, represent a significant compartment for distribution of drugs and endogenous biological metabolites and it has been suggested that these could be factored into pharmacokinetic and pharmacodynamic evaluations. [3] In fact, the binding of low concentrations of polyphenols to red blood cells has been previously reported. [4] [5] [6] Therefore, the possibility of direct blood sampling as the mainstay matrix instead of plasma might yield valuable information in in vivo bioavailability studies of dietary polyphenols.
Moreover, as DBS sampling is based on arterial capillary blood and some amount of interstitial fluid, the concentrations of circulating metabolites could potentially be different from venous blood. As these differences are dependent on the characteristics of particular drugs or diet xenobiotics, case-to-case evaluation is necessary to validate the method. [7] The analysis of phenolic metabolites in human blood was successfully applied in our previous studies after the acute intake of strawberry tree fruit, [8] and an olive oil phenolic extract. [9] In these studies, the blood was collected with microcapillary blood collection tubes, and a fixed volume of blood was spotted onto the filter paper with a micropipette. However, a simplified strategy to quantify the phenolic metabolites by placing blood directly onto the DBS cards has not been tested.
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The aim of the present study was to develop and validate an analytical method based on the combination of DBS cards as simple sampling procedure combined with a sensitive chromatographic method (ultra-performance LC coupled to MS/MS, UPLC-MS/MS) to analyze the main circulating phenolic metabolites in blood and plasma after a human acute intake of a red-fleshed apple snack. The method was validated in terms of linearity, reproducibility, method detection limits, method quantification limits, accuracy, and matrix effects. Specifically, the study focuses on three issues: 1) the comparison of venous and capillary blood sampling, 2) the assessment of the differences between plasma and whole blood, and 3) the comparison of DBS cards and microElution solid phase extraction (µSPE), as the most common method for the analysis of circulating phenolic metabolites in plasma.
Experimental Section

Chemicals and Reagents
The commercial standard 3-(2 ,4 -dihydroxyphenyl)propionic acid was purchased from Fluka (Buchs, Switzerland), epicatechin was from Sigma-Aldrich (St Louis, MO, USA), and phloretin-2 -O-glucoside from Extrasynthese (Genay, France). Catechol-4-O-sulphate and 4-methyl catechol sulphate were supplied by Dr. Claudia N. Santos (IBET, Oeiras, Portugal) and synthetized according to the method reported by Pimpao et al. [10] Stock solutions of individual phenolic standard compounds were prepared by dissolving each compound in methanol at a concentration of 1000 mg L -1 , and storing these in dark flasks at 4°C. Acetonitrile (HPLC-grade) was from Romil (Tecknokroma, Barcelona, Spain). Methanol (HPLC-grade), phosphoric acid (85 %), and glacial acetic acid (99.8 %) were from Scharlau S.L. (Barcelona, Spain). Ultrapure water was obtained from a Milli-Q water purification system (Millipore Corp., Bedford, MA, USA).
Red-Fleshed Apple Snack
The red-fleshed apple variety used was 'Redlove Era' and was provided by Nufri (Mollerussa, Lleida, Spain) and planted in the experimental plot at La Rasa (Soria, Spain). Immediately after the fresh apples arrived at the laboratory, they were washed, wiped with paper towels and cut into 1 cm cubes. The apple cubes were frozen in liquid nitrogen and freeze-drying was then performed with a first drying at 0.6 bar with a temperature ramp of -20 to 0°C for 25 h, followed by a second complete vacuum drying with a temperature ramp of 0 to 20°C for 40 h (Lyophilizer TELSTAR Lyobeta 15, Terrassa, Spain). After that, the apple snack was preserved in a desiccator protected from light.
For the quantification of phenolic compounds, 0.1 g of crushed apple snack was analyzed according to previous study. [11] The phenolic dose ingested through a portion of 80 g of red-fleshed apple snack is shown in Table 1 , where 46% were phenolic acids (mainly chlorogenic acid), 22% were anthocyanins (mainly cyanidin-3-O-galactoside), 17% dihydrochalcones (mainly phloretin glucoside derivatives), 9% flavonols (mainly quercetin derivatives), 7% flavan-3-ols (mainly epicatechin and dimer), and 0.2% flavanone (mainly eriodictyol derivatives). 
Study Design and Blood Sample Collection
The protocol of the study was approved by the Ethical Committee of Human Clinical Research at the Arnau Vilanova University Hospital, Lleida, Spain (approval number: 13/2016). Ten heathy volunteers (five females and five males, mean age 37.3 ± 8.4 years) were recruited and exclusion criteria were age <25 or >50 years, body mass index <18.5 or >24.9 kg m -2 , pregnancy or lactation, any chronic medication, any antibiotic treatment during the 4 months prior to the study, cigarette smoking, alcohol intake >80 g d -1 , and use of dietary supplements. Subjects were asked to avoid the consumption of polyphenol-rich foods (e.g., coffee, fruit, vegetables, dark chocolate, green tea, and red wine) for the 3 days prior to the study. On the day of the study, the participants were invited to eat a portion of 80 g of red-fleshed apple snack after fasting overnight. Capillary blood, venous blood, and plasma samples were obtained at the baseline and at different time points after consumption of the apple snack (0 to 24 h). During this period, the participants avoided the consumption of polyphenol-rich foods. Capillary blood was obtained by fingerpricking and blood drops were directly applied to DBS cards at 0, 0.5, 1, 2, 4, 6, 12, and 24 h. Venous blood was collected by www.advancedsciencenews.com www.mnf-journal.com venipuncture at 0, 0.5, 1, 2, 4, 6, and 24 h in 6 mL Vacutainer tubes (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) containing EDTA as an anticoagulant. To obtain plasma samples, the blood tubes were centrifuged at 8784 × g for 15 min (Hettich, Tuttlingen, Germany). The blood and plasma samples were aliquoted and stored at −80°C until further processing.
Blood and Plasma Samples Pretreatment
DBS Cards
Capillary blood samples were obtained by pricking the volunteers' fingers with disposable lancets (Unistik, Owen Mumford Ltd, Woodstock, UK) and collected on FTA DMPK-A cards (DBS filter paper) (GB Healthcare, Buckinghamshire, UK). The first droplet was discarded, since the initial flow from the 'prick' can be contaminated with interstitial fluid, and good practice warrants discarding this first drop. After that, blood droplets were directly spotted on to two premarked circles on the filter papers until they were completely soaked, while avoiding direct contact between the finger and the card. Venous blood obtained by venipuncture and the corresponding plasma samples were also applied to DBS cards. Thirty microliters of venous blood or plasma was defined as the exact volume to completely fill each premarked circle. The pretreatment procedure is depicted in Figure 1A .
In order to dry the spotted cards, they were maintained in the dark at room temperature for 2 h. Afterward, in order to extract and preconcentrate the target compounds, the whole surface of two blood or plasma-soaked circles were punched out using a 3-mm diameter Harris Uni-Core punch and a Cutting Mat (Whatman Inc., Sanford, ME, USA). Different conditions were tested for extracting the analytes, and the optimal conditions appeared www.advancedsciencenews.com www.mnf-journal.com to be 150 µL of methanol/Milli-Q water (50:50, v/v) as the elution solvent, vortexed for 20 min and centrifuged at 8784 × g for 10 min at room temperature. The supernatant was filtered with 0.22 µL Nylon 96-well filter microplate (Agilent technologies, Santa Clara, CA, USA), and 7.5 µL of the filtered solution was injected into the chromatographic system.
µSPE Cartridges
µSPE was also applied for the analysis of the main circulating phenolic metabolites in venous plasma samples as it is the most common sample pretreatment method used in previous studies, and the obtained results were compared to those achieved from plasma by using DBS cards. The µSPE methodology used was based on previous studies. [12, 13] Briefly, the µElution plates (OASIS HLB 30 µm, Waters, Milford, MA, USA) were activated with 250 µL of methanol and equilibrated with 250 µL of 0.2% acetic acid. 350 µL of venous plasma and 350 µL of 4 % phosphoric acid were centrifuged at 8784 × g for 10 min at 4°C, and the supernatant was loaded into the microcartridge. The loaded microcartridges were cleaned-up with 200 µL of Milli-Q water and 200 µL of 0.2% acetic acid. Then, the retained compounds were eluted with 2 × 50 µL of methanol. Eluted solution (2.5 µL) was directly injected into the chromatographic system ( Figure 1B ).
Phenolic Metabolites Analysis by UPLC-MS/MS
The phenolic compounds and their generated metabolites were determined in blood and plasma samples by AcQuity UPLC coupled to a triple quadrupole detector (TQD) mass spectrometer (Waters, Milford). The analytical column was an AcQuity BEH C 18 column (100 mm × 2.1 mm id, 1.7 µm) equipped with a VanGuard Pre-Column AcQuity BEH C 18 (2.1 × 5 mm, 1.7 µm), also from Waters. During the analysis, the column was kept at 30°C, and the flow rate was 0.3 mL min −1 . The mobile phase and elution gradient were the same as those reported in previous studies. [8, 11] MS/MS analyses were carried out on a TQD mass spectrometer (Waters, Milford, MA, USA) equipped with a Z-spray electrospray interface. Ionization was achieved using the electrospray interface operating in the negative mode [M−H] − and the data were acquired through selected reaction monitoring (SRM). The ionization source parameters were the same as the ones reported in previous studies. [8, 11] Two SRM transitions were selected, the most sensitive one was used for quantification, and the second for confirmation purposes. Table S1 , Supporting Information shows the SRM transition for quantification and identification, as well as the cone voltage and collision energy for each phenolic metabolite. The dwell time established for each transition was 30 ms. Data acquisition was carried out with the MassLynx 4.1 software. Due to the lack of commercial standards of phenolic metabolites, some of these compounds were tentatively quantified by using the calibration curve of their native compound or another phenolic compound with a similar structure. Phloretin glucuronide was tentatively quantified by using the calibration curve of phloretin-2 -O-glucoside, dihydroxyphenylpropionic acid sulphate by using the calibration curve of 3-(2 ,4 -dihydroxyphenyl)propionic acid, and hydroxyphenyl-γ -valerolactone by using the calibration curve of epicatechin. Catechol sulphate and methyl catechol sulphate were quantified with their own calibration curves, and catechol glucuronide by using the calibration curve of catechol-4-Osulphate.
Validation Procedure
The instrumental quality parameters of the developed methods, such as linearity, precision, accuracy, detection limits (LODs), and quantification limits (LOQs), as well as the extraction recovery (%R) and matrix effect (%ME) for the determination of the main phenolic metabolites in blood and plasma samples by DBS cards, and plasma samples by µSPE, were determined by spiking blank biological samples (venous blood and plasma samples obtained under fasting conditions) with known concentrations of standard phenolic compounds. Calibration curves were prepared with venous blood, since it was not possible to obtain large volumes of blank capillary blood. These instrumental quality parameters, as well as the %R and %ME, were determined as reported in previous study, [14] and the results obtained are shown in Table 2 .
Statistical Analysis
The quantitative data were analyzed by Student's t-test in order to determine significant differences between mean values of the concentration of the main circulating apple phenolic metabolites in: 1) the capillary and venous blood at different post-intake times, 2) the venous blood (venipuncture) and plasma samples (venipuncture) at different times, and 3) the venous plasma analyzed by DBS cards and by µSPE at different times. Significant differences were considered at the level of p < 0.05. All the statistical analyses were carried out using STATGRAPHICS Plus 5.1 (Manugistics Inc., Rockville, MD, USA).
Results and Discussion
Optimization of DBS Technique for Phenolic Metabolite Analysis
This work was based on our previous studies, where phenolic metabolites were determined in plasma or blood samples after the acute intake of strawberry tree fruit [8] and olive oil phenolic extract. [9] In these previous studies, 20 µL of venous blood or plasma were spotted onto one premarked circle on the DBS and seven disks of 2 mm diameter were punched out from the card using 100 µL of methanol/Milli-Q water (50/50, v/v) for the phenolic extraction. Under these experimental conditions, only the most abundant circulating phenol metabolites were detected. In the present study, in order to enhance the method sensitivity, different conditions were tested to improve the extraction and increase the preconcentration of the analytes. We also aimed to www.advancedsciencenews.com www.mnf-journal.com explore a strategy to quantify the phenolic metabolites directly by depositing blood droplets on DBS card in order to simplify the process. The factors studied were: (i) the blood volume spotted on the premarked circle (from 20 to 50 µL), (ii) the number of disks punched out from the card (from seven disks to the entire premarked circle) and the number of the premarked circles (1 or 2), (iii) the nature of the extraction solvent (methanol, methanol/Milli-Q water (50/50, v/v), and acetonitrile), and its volume (from 100 to 200 µL), and (iv) the extraction time with vortex (from 5 to 30 min).
In the present study, six different phenolic metabolites derived from phase II and microbial metabolism were detected in both the blood and plasma human samples. Specifically, the main metabolites detected were phloretin glucuronide, dihydroxyphenylpropionic acid sulphate, (methyl) catechol sulphate, catechol glucuronide, and hydroxyphenyl-γ -valerolactone glucuronide. Therefore, to optimize the method different phenol standards as catechol-4-O-sulphate, 4-methyl catechol sulphate, 3-(2 ,4 -dihydroxy-phenyl)propionic acid, epicatechin, and phloretin-2 -O-glucoside were spiked at known concentrations into a pooled venous human blood obtained under fasting conditions.
Blood Volume Spotted on the Premarked Circle
Four different blood volumes applied to the cards were tested (20, 30, 40 , and 50 µL) (data not shown). In our previous study, volumes from 5 to 20 µL were tested and a greater instrumental response of the phenolic standards was reported as the blood volume increased. [9] In the present study, 30 µL was selected as the optimum volume observing that, with this volume, one premarked circle was entirely soaked to its edge with all volunteers' blood samples. This fact denoted that the viscosity of the blood from all volunteers was similar as were its spreading properties on the DBS cards, thus indicating a similar hematocrit.
When droplet of capillary blood is directly deposited on the filter paper, the volume of this blood cannot be precisely controlled and inaccuracies in quantification values can be obtained due to differences in hematocrit. In the literature, different strategies to overcome this drawback have been proposed, such as the use of volumetric absorptive microsampling (VAMS) [15] or the photometric measurement of the protein content. [16] In the present study, a simplified strategy to quantify the phenolic metabolites was tested, assuming a linear relation between volume of blood applied and the area of the premarked DBS circle. In this sense, www.advancedsciencenews.com www.mnf-journal.com we asked volunteers to soak the entire surface of the premarked circles with capillary blood, estimating that the entire surface of one premarked circle contained 30 µL of capillary blood, as observed when a fixed volume of the volunteers' blood was dispensed on to the DBS.
Spot Punch Surface
In the present study, the fact of punching out the maxim number of disks (eight 2-mm diameter disks) or the entire surface of the premarked circle was tested and the instrumental response of all the phenolic compounds studied increased slightly when the entire premarked circle was analyzed (data not shown). Moreover, in a previous study, it was reported that the whole spot approach can effectively avoid any hematocrit effect in the analysis of a specific drug (apixaban) in human DBS samples compared to a partial spot-center punch. [17] Moreover, the fact of analyzing two instead of one premarked circles with reduced elution solvent volume was also tested, and a major preconcentration effect of the target compounds was observed.
Extraction Solvent Volume and Nature
The tested elution volumes were 100, 150, and 200 µL. The use of 100 µL was discarded because this was not large enough to cover two entire premarked circles. Volumes of 150 and 200 µL allowed the phenolics to be extracted with good %R, but with 150 µL, a higher preconcentration rate was obtained and the %R and %ME were not significantly affected (data not shown). Different elution solvents were also tested in order to obtain the maximum sensitivity (peak efficiency or narrow peaks) and maximum extraction recovery (%R). Among all the elution solvents tested, methanol/Milli-Q water (50/50, v/v) was the optimum in terms of peak efficiency, and %R, and therefore this elution solvent was chosen.
Extraction Time
First, the extraction time (vortex) of the disks with the elution solvent was optimized, and 5, 10, 20, and 30 min were tested. It was observed that the extraction of the main phenolic metabolites increased with the extraction time and this fact was observed until 20 min with no differences between 20 and 30 min, so 20 min was selected as the optimum time (data not shown). So, the optimum pretreatment conditions with DBS cards were defined as: 30 µL of venous blood in each premarked circle, punching out the entire surface of two premarked circles, 150 µL of methanol/Milli-Q water (50/50, v/v) solution as the extraction solvent and 20 min as the extraction time (vortex) ( Figure 1A) . The same conditions were used for the venous plasma and capillary blood. Under these experimental conditions, the %R of all the studied phenolics was above 75% and the %ME was lower than 18% (Table 2) .
Analytical Methods Validation
The instrumental quality parameters of the developed methods using DBS cards for the analysis of the venous blood and plasma samples, and µSPE for the analysis of plasma samples, are shown in Table 2 . In order to carry out these studies, catechol-4-O-sulphate, 4-methyl catechol sulphate, 3-(2 ,4 -dihydroxyphenyl)propionic acid, epicatechin, and phloretin-2 -O-glucoside were spiked into blank venous blood samples and blank plasma samples at different known concentrations. The linearity range was from 0.04 to 10 µm for venous blood, and 0.03 to 10 µm for plasma samples when DBS cards were used; and 0.0008 to 10 µm for plasma samples when µSPE was used.
The calibration curves (based on the integrated peak area) were calculated by using five points at different concentration levels, and each concentration was injected three times. The determination coefficient (R 2 ) of the calibration curves was higher than 0.993. The precision of the analytical method (reproducibility) were determined by the %RSD in terms of concentration, and these were calculated at three concentration levels, these being 5, 0.1, and 0.01 µm for the analysis of venous blood and plasma samples (Table 2) . For all the phenolic compounds the %RSDs were lower than 10% in both DBS cards and µSPE methods. The accuracy was calculated from the ratio between the concentration found for the standard phenolic compounds studied compared with the spiked concentration. This quotient was then multiplied by 100. This quality parameter was also studied at three concentration levels, the same as for the RSD%, and these ranged from 97% to 103%.
The LODs and LOQs were calculated using the S/N ratio criterion of 3 and 10, respectively. The respective values were in the 15-30 and 45-95 nm ranges for venous blood samples, and the 15-25 and 34-75 nm ranges for plasma samples when DBS cards were used. These results were tenfold lower to our previous study where olive oil phenol metabolites were determined in blood samples using DBS cards. [9] So, the fact of punching two entire premarked circles and decrease the elution solvent volume, improved the sensitivity of the method.
The LODs and LOQs in the analysis of plasma samples by µSPE were 0.3-20 and 0.8-50 nm, respectively. It is important to highlight the lower LODs and LOQs in comparison with DBS cards. This fact could be explained by the analyte preconcentration (3.5-fold) that is performed in µSPE (350 µL of plasma are loaded and 100 µL elution solvent are used to elute). Nevertheless when DBS cards are used, the analytes are diluted (2.5-fold). So, 60 µL of biological samples are directly deposited in the circles of the DBS card (two circles with 30 µL each one) and then 150 µL of extraction solvent are used to analyze the compounds of interest.
The %R for the analysis of the studied phenolics in venous blood and plasma samples (in both DBS cards and µSPE) were similar and these were higher than 75% (Table 2) , except for (methyl) catechol sulphate in µSPE, being between 59% and 63%. The %ME for the analysis of the studied phenolics in these biological samples was lower than 15%, being lower in the µSPE pretreatment (Table 2) . Figure 2 shows the time course of the main generated phenolic metabolites determined in capillary blood, venous blood, and venous plasma using DBS cards at different time points (0-24 h) after the acute intake of red-fleshed apple snack. When comparing mean values of capillary blood versus venous blood, no significant differences (p > 0.05) were observed in any metabolite or at any time point. Previous studies with drugs found concentrations about 1.7 times higher in capillary than venous blood, [18] but these differences are dependent on the characteristics of particular compounds, so case-to-case evaluation is necessary. The results of the present study indicate that in the case of apple phenolic metabolites, values do not differ significantly between venous blood and capillary blood.
Capillary Blood versus Venous Blood in DBS Cards
Regarding the time-course data, the maximum concentration of the circulating metabolites phloretin glucuronide and dihydroxyphenylpropionic acid sulphate was found between 2 and 4 h, indicating their metabolic transformation in the small intestine and liver (Figure 2) . The other metabolites (catechol sulphate, methyl catechol sulphate, catechol glucuronide, and hydroxyphenyl-γ -valerolactone glucuronide) appeared to have their maximum concentrations 12 h after consumption of the apple snack, indicating that they could be products of the gut microbiota catabolism in the colon.
One of the most important advantages of using DBS cards reported in the present study is the possibility of analyzing more post-intake time points by self-sampling compared to venipuncture. Particularly, the possibility of taking sample at 12 h enabled the detection and quantification of two microbial metabolites (catechol glucuronide and hydroxyphenyl-γ -valerolactone glucuronide) (Figure 2 ). These results indicate the importance of collecting these time points to gain deeper insights into the in vivo distribution of metabolites produced by gut microbiota.
Venous Blood versus Venous Plasma Samples in DBS Cards
The concentration values of the phenolic compounds determined in venous blood samples after the acute intake of the red apple snack were also compared to those obtained for the analysis of their corresponding plasma samples and the results showed no significant differences in any metabolite at any time point (Figure 2) . Pharmacokinetic studies are commonly carried out focusing on the levels of phenolic metabolites in plasma or serum. However, in the case of some polyphenols their affinity for human blood cells has been observed. For instance, quercetin [19, 20] and resveratrol [21] are known to partition into blood cells, associating with cell membranes, hemoglobin, and other proteins. The binding of low concentrations of polyphenols to erythrocytes was also reported for caffeic acid, taxifolin, and ferulic acid in a human study [6] and hydroxytyrosol phase-II metabolites in a rat model. [5] In a recent study, it was also reported a differential distribution of phenolic compounds between serum and blood cells depending on the characteristics of particular polyphenols, [22] confirming that case-to-case evaluation is necessary.
As shown in Figure 2 , in the case of phenolic metabolites derived mainly from phenolic acids and anthocyanins from apple, plasma levels appear to be lower than blood concentration. However, no significant differences were found between blood and plasma, probably due to the large interindividual variability in the phenolic metabolism.
Based on our results and also considering previous studies, the application of DBS cards with blood as the mainstay matrix might yield valuable information as a practical alternative to classic plasma analysis to determine the in vivo human absorption of phenolic metabolites.
DBS Cards versus µSPE for Venous Plasma Samples
µSPE is the sample pretreatment technique most commonly used to extract phenolic metabolites from plasma samples. However, this technique requires venipuncture to obtain a sufficient volume of blood sample and subsequently of plasma sample. In order to evaluate whether DBS cards can be an alternative strategy to µSPE, venous plasma samples were analyzed by using both methods. Table 3 shows the average concentrations from the ten healthy volunteers of the main phenolic metabolites and no significant differences were detected among both methods. Although the sensitivity (LODs and LOQs) of DBS cards technique was lower than µSPE, the average concentrations of the main phenolic metabolites detected in plasma did not significantly differ between the two sample pretreatment techniques. Therefore, we conclude that DBS cards has the limitation of its inability to accurately quantify low-level minor metabolites, but is still a suitable strategy for the analysis of the main phenolic intake biomarkers in human interventional studies, and also for urine analysis as we reported previously. [12] 
Concluding Remarks
A method based on DBS cards combined with LC (UPLC-MS/MS) was developed and validated for the determination of phenolic metabolites in human blood and plasma samples. DBS cards has been reported as a rapid and easy blood-sampling strategy to determine the main circulating phenolic metabolites after an acute intake of red-fleshed apple snack. The comparison of capillary and venous sampling and also the assessment of the differences between whole blood and plasma samples showed no significant differences. In addition, there were no significant differences among DBS cards and µSPE.
The self-sampling of blood by the volunteers following simple instructions, allowed more time points to be collected during postprandial period, especially those late time points (12 h) to assess the intestinal microbial metabolism of phenolic compounds, which are normally missing with venipuncture. Our study reveals that finger-prick blood sampling based on DBS cards appears to be a suitable alternative to the classic invasive venipuncture for determining phenolic metabolites, including microbial fermentation catabolites, in human polyphenol bioavailability and pharmacokinetic studies.
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